Loading clinical trials...
Loading clinical trials...
An Exploratory Evaluation of Interleukin 28B (IL28B) Genotype, Single Nucleotide Polymorphisms (SNP) of rs12356193, Protein and RNA Biomarkers in Serum Samples (Stored, Already Obtained From Completed Studies) From Subjects With HBe-antigen Positive or Negative Chronic Hepatitis B, Who Have Completed Therapy for Hepatitis B With Pegasys ± Lamivudine.
Conditions
Locations
27
Australia
Herston, Queensland, Australia
Fitzroy, Victoria, Australia
Clichy, France
Hong Kong, Hong Kong
Hong Kong, Hong Kong
Bari, Apulia, Italy
Start Date
June 1, 2012
Primary Completion Date
February 1, 2013
Completion Date
February 1, 2013
Last Updated
November 2, 2016
NCT04166266
NCT06550622
NCT05922306
NCT05870969
NCT04856085
NCT04780204
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions